A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 11, 2017

Study Completion Date

February 1, 2017

Conditions
SchizophreniaAlcohol Use Disorder
Interventions
DRUG

Samidorphan + olanzapine (ALKS 3831)

Oral tablet, taken once daily

DRUG

Placebo + olanzapine

Oral tablet, taken once daily

Trial Locations (71)

1282

Alkermes Investigational Site, Novi Iskar

1606

Alkermes Investigational Site, Sofia

3000

Alkermes Investigational Site, Vratsa

5500

Alkermes Investigational Site, Lovech

6100

Alkermes Investigational Site, Kazanlak

8000

Alkermes Investigational Site, Burgas

8260

Alkermes Investigational Site, Tserova Koria

9002

Alkermes Investigational Site, Varna

9020

Alkermes Investigational Site, Varna

10021

Alkermes Investigational Site, New York

10032

Alkermes Investigational Site, New York

10035

Alkermes Investigational Site, New York

10312

Alkermes Investigational Site, Staten Island

11423

Alkermes Investigational Site, Jamaica

11516

Alkermes Investigational Site, Cedarhurst

14642

Alkermes Investigational Site, Rochester

18503

Alkermes Investigational Site, Scranton

20016

Alkermes Investigational Site, Washington D.C.

29401

Alkermes Investigational Site, Charleston

29407

Alkermes Investigational Site, Charleston

29425

Alkermes Investigational Site, Charleston

30030

Alkermes Investigational Site, Decatur

30308

Alkermes Investigational Site, Atlanta

30912

Alkermes Investigational Site, Augusta

32751

Alkermes Investigational Site, Maitland

32803

Alkermes Investigational Site, Orlando

33021

Alkermes Investigational Site, North Miami

33122

Alkermes Investigational Site, Miami

33136

Alkermes Investigational Site, Miami

33308

Alkermes Investigational Site, Fort Lauderdale

33334

Alkermes Investigational Site, Oakland Park

33613

Alkermes Investigational Site, Tampa

34748

Alkermes Investigational Site, Leesburg

39232

Alkermes Investigational Site, Flowood

45417

Alkermes Investigational Site, Dayton

60169

Alkermes Investigational Site, Hoffman Estates

60523

Alkermes Investigational Site, Oak Brook

60640

Alkermes Investigational Site, Chicago

63118

Alkermes Investigational Site, St Louis

63141

Alkermes Investigational Site, Creve Coeur

64108

Alkermes Investigational Site, Kansas City

71101

Alkermes Investigational Site, Shreveport

72211

Alkermes Investigational Site, Little Rock

72764

Alkermes Investigational Site, Springdale

73112

Alkermes Investigational Site, Oklahoma City

75115

Alkermes Investigational Site, DeSoto

75214

Alkermes Investigational Site, Dallas

78754

Alkermes Investigational Site, Austin

89102

Alkermes Investigational Site, Las Vegas

90230

Alkermes Investigational Site, Culver City

90502

Alkermes Investigational Site, Torrance

90822

Alkermes Investigational Site, Long Beach

91950

Alkermes Investigational Site, National City

92037

Alkermes Investigational Site, La Jolla

92056

Alkermes Investigational Site, Oceanside

92123

Alkermes Investigational Site, San Diego

92617

Alkermes Investigational Site, Irvine

92805

Alkermes Investigational Site, Anaheim

92845

Alkermes Investigational Site, Garden Grove

92868

Alkermes Investigational Site, Orange

94121

Alkermes Investigational Site, San Francisco

94612

Alkermes Investigational Site, Oakland

98007

Alkermes Investigational Site, Bellevue

97-400

Alkermes Investigational Site, Bełchatów

15-464

Alkermes Investigational Site, Bialystok

80-546

Alkermes Investigational Site, Gdansk

20-109

Alkermes Investigational Site, Lublin

01605

Alkermes Investigational Site, Worcester

03743

Alkermes Investigational Site, Claremont

03060

Alkermes Investigational Site, Nashua

07753

Alkermes Investigational Site, Neptune City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alkermes, Inc.

INDUSTRY